Partial Epilepsy Clinical Trial
— EEG-HROfficial title:
Etude de la Performance Diagnostique de l'EEG-Haute Résolution Sur la Localisation de la Zone épileptogène Pour le Traitement Chirurgical Des épilepsies Partielles Pharmaco-résistantes
Multicenter prospective study comparing the diagnosis value of high-resolution EEG and depth-EEG to localize the epileptogenic zone in drug resistant partial epilepsies.
Status | Completed |
Enrollment | 115 |
Est. completion date | November 2013 |
Est. primary completion date | October 2013 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 15 Years and older |
Eligibility |
Inclusion Criteria: - medically intractable patial epilepsy confirmed by video-EEG recordings of epileptic seizures. - Depth EEG (Stereo-EEG) required to delineate the epileptogenic zone and define the surgical procedure. - full informed consent of the patient (or of his/ her legal representative) - 15 year or older patient Exclusion Criteria: - contraindication to cortectomy - contraindication to depth-EEG - indication of epilepsy surgery without depth-EEG monitoring - high grade glioma, arterio-veinous malformations - pregnancy - history of severe cardio-vascular event (coronaropathy, stroke) |
Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Country | Name | City | State |
---|---|---|---|
France | University Hospital of Marseille | Marseille | |
France | Central Hospital | Nancy |
Lead Sponsor | Collaborator |
---|---|
Central Hospital, Nancy, France | CHU de Reims, France: Centre National de la Recherche Scientifique, Institut National de la Santé Et de la Recherche Médicale, France, University Hospital, Marseille |
France,
Koessler L, Benar C, Maillard L, Badier JM, Vignal JP, Bartolomei F, Chauvel P, Gavaret M. Source localization of ictal epileptic activity investigated by high resolution EEG and validated by SEEG. Neuroimage. 2010 Jun;51(2):642-53. doi: 10.1016/j.neuroimage.2010.02.067. Epub 2010 Mar 4. — View Citation
Koessler L, Cecchin T, Caspary O, Benhadid A, Vespignani H, Maillard L. EEG-MRI co-registration and sensor labeling using a 3D laser scanner. Ann Biomed Eng. 2011 Mar;39(3):983-95. doi: 10.1007/s10439-010-0230-0. Epub 2010 Dec 8. — View Citation
Koessler L, Salido-Ruiz R, Ranta R, Louis-Dorr V, Gavaret M, Maillard L. Influence of source separation and montage on ictal source localization. Conf Proc IEEE Eng Med Biol Soc. 2010;2010:2898-901. doi: 10.1109/IEMBS.2010.5626321. — View Citation
Maillard L, Koessler L, Colnat-Coulbois S, Vignal JP, Louis-Dorr V, Marie PY, Vespignani H. Combined SEEG and source localisation study of temporal lobe schizencephaly and polymicrogyria. Clin Neurophysiol. 2009 Sep;120(9):1628-36. doi: 10.1016/j.clinph.2009.06.022. Epub 2009 Jul 24. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Sensitivity and specificity of electrical source localization of inter-ictal and ictal discharges using high-Resolution EEG for localizing the epileptogenic zone (the stereo-electroencephalography will be the reference method) | results of electrical sources localization of inter-ictal and ictal discharges are compared to the epileptogenic zone defined by SEEG | 3 years | No |
Secondary | inter-observer reliability of electrical source localization of inter-ictal and ictal discharges for localizing the epileptogenic zone. | sources localization of inter-ictal and ictal discharges will be interpreted by two independant epileptologists, blinded to the results of stereo-EEG. | 3 years | No |
Secondary | sensitivity and specificity of high resolution EEG and electrical source imaging for surgical decision | decision of surgery and the limits of the cortectomy established with electrical source imaging will be compared to the decision of surgery and the limits of the cortectomy established with Stereo-electroencephalography. | 3 years | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT00982787 -
Safety and Anticonvulsant Efficacy of Passiflora Incarnata Extract in Patients With Partial Epilepsy
|
Phase 2 | |
Completed |
NCT00898560 -
Effect of Repeat Administration of Eslicarbazepine Acetate on the Pharmacokinetics of a Combined Oral Contraceptive
|
Phase 1 | |
Recruiting |
NCT01735032 -
Multimodal Imaging in Pre-surgical Evaluation of Epilepsy
|
N/A | |
Terminated |
NCT00391534 -
EXTENT: EXtended Tolerability and Efficacy of a Novel Formulation of Oxcarbazepine in a Trial in Partial Epilepsy
|
Phase 3 | |
Terminated |
NCT01496612 -
Buspirone Therapy for Localized Epilepsy
|
Phase 2 | |
Completed |
NCT00900237 -
Study to Evaluate Pharmacokinetics and Tolerability of Multiple Doses of Eslicarbazepine Acetate and Oxcarbazepine
|
Phase 1 | |
Recruiting |
NCT04903314 -
Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures
|
Phase 1 | |
Completed |
NCT01373190 -
Thermographic Examination of Skin Temperatures in Individuals With Focal Onset Epilepsy
|
N/A | |
Completed |
NCT00894478 -
Improving Lesion Detection in Children With Magnetic Resonance Imaging (MRI)-Negative Partial Epilepsy Using Diffusion Tensor Imaging
|
N/A | |
Recruiting |
NCT03478852 -
Investigating Epilepsy: Screening and Evaluation
|
||
Recruiting |
NCT01273129 -
Surgery as a Treatment for Medically Intractable Epilepsy
|
||
Completed |
NCT00001666 -
Transcranial Magnetic Stimulation for the Treatment of Poorly Controlled Partial Epilepsy
|
N/A | |
Completed |
NCT00001932 -
Serotonin Receptors in Seizure Disorders
|
N/A | |
Completed |
NCT00908349 -
Safety and Tolerability of OXC XR as Adjunctive Therapy in Subjects With Refractory Partial Epilepsy
|
Phase 3 | |
Completed |
NCT02076698 -
Deep Brain Stimulation of the Anterior Nucleus of the Thalamus in Epilepsy
|
Phase 3 | |
Completed |
NCT00706160 -
Language Mapping in Patients With Epilepsy
|
||
Completed |
NCT01397968 -
Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures
|
Phase 2 | |
Completed |
NCT01866111 -
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
|
Phase 2 | |
Completed |
NCT00957047 -
Efficacy and Safety Study of BIA 2-093 in Combination With Other Anti-Epileptic Drugs to Treat Partial Epilepsy
|
Phase 3 | |
Terminated |
NCT01281956 -
PRX-00023 Therapy in Localization-Related Epilepsy
|
Phase 2 |